{"id":"W2345984910","doi":"10.1038/cgt.2016.18","title":"Breast cancer gene therapy using an adenovirus encoding human IL-2 under control of mammaglobin promoter/enhancer sequences","year":2016,"lang":"en","type":"article","venue":"Cancer Gene Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Alberta","funders":"Breast Cancer Alliance","keywords":"Telomerase reverse transcriptase; Enhancer; Mammaglobin; Viral vector; Genetic enhancement; Luciferase; Biology; Vector (molecular biology); Promoter; Cancer research; Molecular biology; Reporter gene; Gene; Telomerase; Cancer; Transfection; Breast cancer; Recombinant DNA; Gene expression; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003770036,0.0004959,0.0002491019,0.0005810329,0.0002046476,0.0004516487,0.0002245529,0.0003592813,0.001536863],"category_scores_gemma":[0.0001239779,0.000199322,0.0003257335,0.0002785404,0.0003414736,0.0003057294,0.0002584557,0.0007652995,0.0004723334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005167981,"about_ca_system_score_gemma":0.0004872685,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000934833,"about_ca_topic_score_gemma":0.001194513,"domain_scores_codex":[0.9998111,0.00004017832,0.00001424855,0.00004358193,0.00004186284,0.00004906618],"domain_scores_gemma":[0.9999141,0.00002660654,0.00001903603,0.00001413472,0.000008077931,0.00001802806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002497268,0.00008459828,0.0001838992,0.00004001234,0.00000837638,0.00004140383,0.0000298504,0.00009353893,0.9959145,0.0007913935,0.000087804,0.002474842],"study_design_scores_gemma":[0.00005996951,0.0002737788,0.0006438909,0.000007115931,0.0000214968,0.000136841,0.00001651111,0.0007033558,0.9919358,0.00006332817,0.006133653,0.000004231017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9479609,0.004016967,0.03525938,0.000479038,0.0003486217,0.0003775464,0.001082421,0.0006595106,0.009815726],"genre_scores_gemma":[0.9578442,0.00161799,0.02454658,0.0001298219,0.00004696846,0.0001957874,0.001108434,0.0000776848,0.01443258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001536863,"threshold_uncertainty_score":0.005141377,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05321092735661783,"score_gpt":0.3544590337669619,"score_spread":0.3012481064103441,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}